In vitro activity of rifampicin against Helicobacter pylori isolated from children and adults

Shigeru Fujimura, Seiichi Kato, Takeshi Kawamura, Akira Watanabe

    Research output: Contribution to journalArticlepeer-review

    25 Citations (Scopus)

    Abstract

    Antibiotic resistance in Helicobacter pylori has been a growing problem with current treatment regimens. However, second-line therapy for cases with eradication failure remains to be established. The aim of this study was to evaluate (in vitro) the potential use of rifampicin for H. pylori eradication. The susceptibility of 52 H. pylori strains isolated from children and adults to amoxicillin, clarithromycin, metronidazole and rifampicin was determined. Forty H. pylori isolates susceptible to these antibiotics were investigated for in vitro inducement of resistance. All isolates were susceptible to rifampicin. None of the H. pylori isolates tested acquired rifampicin resistance during prolonged exposure in in vitro inducement experiments. It is suggested that rifampicin has stable activity against H. pylori.

    Original languageEnglish
    Pages (from-to)541-543
    Number of pages3
    JournalJournal of Antimicrobial Chemotherapy
    Volume49
    Issue number3
    DOIs
    Publication statusPublished - 2002

    ASJC Scopus subject areas

    • Pharmacology
    • Microbiology (medical)
    • Infectious Diseases
    • Pharmacology (medical)

    Fingerprint Dive into the research topics of 'In vitro activity of rifampicin against Helicobacter pylori isolated from children and adults'. Together they form a unique fingerprint.

    Cite this